CHICAGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Portillo's Inc. ("Portillo's” or the "Company”) (NASDAQ: PTLO), the restaurant ...
Patient enrollment and site activation continues to progress in the Phase 1b PIONEER trial evaluating pociredir in patients with SCD. Fulcrum has enrolled 10 patients in the 12 mg dose cohort, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback